Graig Suvannavejh

Stock Analyst at Mizuho

(3.52)
# 912
Out of 5,017 analysts
164
Total ratings
47.15%
Success rate
6.08%
Average return

Stocks Rated by Graig Suvannavejh

Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Outperform
Price Target: $50$35
Current: $26.29
Upside: +33.13%
IDEAYA Biosciences
Sep 12, 2025
Maintains: Outperform
Price Target: $43$44
Current: $27.03
Upside: +62.78%
BioXcel Therapeutics
Sep 12, 2025
Maintains: Neutral
Price Target: $2$4
Current: $2.53
Upside: +58.42%
KALA BIO
Sep 8, 2025
Initiates: Outperform
Price Target: $30
Current: $1.47
Upside: +1,947.78%
Insmed
Aug 13, 2025
Maintains: Outperform
Price Target: $130$165
Current: $165.87
Upside: -0.52%
Apellis Pharmaceuticals
Aug 4, 2025
Maintains: Neutral
Price Target: $21$22
Current: $24.94
Upside: -11.79%
Alector
Jul 28, 2025
Upgrades: Outperform
Price Target: $2.5$3.5
Current: $2.95
Upside: +18.64%
Neumora Therapeutics
Jul 16, 2025
Maintains: Outperform
Price Target: $4$5
Current: $1.85
Upside: +170.27%
Adverum Biotechnologies
Jun 26, 2025
Maintains: Outperform
Price Target: $16$12
Current: $4.59
Upside: +161.44%
Adaptimmune Therapeutics
Jun 26, 2025
Downgrades: Neutral
Price Target: $1.5$0.5
Current: $0.19
Upside: +160.42%
Maintains: Outperform
Price Target: $8$10
Current: $6.12
Upside: +63.40%
Maintains: Outperform
Price Target: $12$11
Current: $7.27
Upside: +51.31%
Maintains: Outperform
Price Target: $30$26
Current: $13.34
Upside: +94.98%
Maintains: Outperform
Price Target: $7$8
Current: $14.04
Upside: -43.02%
Maintains: Neutral
Price Target: $38$33
Current: $32.94
Upside: +0.18%
Maintains: Outperform
Price Target: $212$216
Current: $120.38
Upside: +79.44%
Upgrades: Buy
Price Target: $7$7.6
Current: $1.68
Upside: +353.73%
Reiterates: Outperform
Price Target: $74
Current: $16.50
Upside: +348.48%
Downgrades: Neutral
Price Target: $50$5
Current: $3.64
Upside: +37.36%
Maintains: Neutral
Price Target: $44$49
Current: $65.33
Upside: -25.00%
Maintains: Buy
Price Target: $14$16
Current: $10.27
Upside: +55.79%
Maintains: Buy
Price Target: $17$10
Current: $8.28
Upside: +20.77%
Downgrades: Neutral
Price Target: $17$1
Current: $4.72
Upside: -78.79%
Maintains: Buy
Price Target: $31$35
Current: $101.27
Upside: -65.44%
Maintains: Neutral
Price Target: $9$8
Current: $11.77
Upside: -32.03%
Maintains: Buy
Price Target: $71$57
Current: $60.99
Upside: -6.54%
Maintains: Sell
Price Target: $8$5
Current: $34.03
Upside: -85.31%
Initiates: Buy
Price Target: $34
Current: $10.50
Upside: +223.81%
Initiates: Neutral
Price Target: $28
Current: $6.51
Upside: +330.11%
Initiates: Neutral
Price Target: $31
Current: $15.04
Upside: +106.12%
Initiates: Sell
Price Target: $380
Current: $32.88
Upside: +1,055.72%
Initiates: Neutral
Price Target: $4.75
Current: $2.01
Upside: +136.32%
Upgrades: Buy
Price Target: $36
Current: $20.48
Upside: +75.78%
Downgrades: Sell
Price Target: n/a
Current: $34.18
Upside: -
Initiates: Neutral
Price Target: $37
Current: $1.27
Upside: +2,824.90%
Downgrades: Sell
Price Target: $128
Current: $134.39
Upside: -4.75%